Severe peri-ictal respiratory dysfunction is common in Dravet syndrome

Dravet syndrome (DS) is a severe childhood-onset epilepsy commonly due to mutations of the sodium channel gene SCN1A. Patients with DS have a high risk of sudden unexplained death in epilepsy (SUDEP), widely believed to be due to cardiac mechanisms. Here we show that patients with DS commonly have peri-ictal respiratory dysfunction. One patient had severe and prolonged postictal hypoventilation during video EEG monitoring and died later of SUDEP. Mice with an Scn1aR1407X/+ loss-of-function mutation were monitored and died after spontaneous and heat-induced seizures due to central apnea followed by progressive bradycardia. Death could be prevented with mechanical ventilation after seizures were induced by hyperthermia or maximal electroshock. Muscarinic receptor antagonists did not prevent bradycardia or death when given at doses selective for peripheral parasympathetic blockade, whereas apnea, bradycardia, and death were prevented by the same drugs given at doses high enough to cross the blood-brain barrier. When given via intracerebroventricular infusion at a very low dose, a muscarinic receptor antagonist prevented apnea, bradycardia, and death. We conclude that SUDEP in patients with DS can result from primary central apnea, which can cause bradycardia, presumably via a direct effect of hypoxemia on cardiac muscle.
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research

Related Links:

Jose Eduardo Peixoto-Santos, Luciana Estefani Drumond de Carvalho, Ludmyla Kandratavicius, Paula Rejane Beserra Diniz, Renata Caldo Scandiuzzi, Roland Coras, Ingmar Bl ümcke, Joao Alberto Assirati, Carlos Gilberto Carlotti, Caio Cesar Marconato Simoes Matias, Carlos Ernesto Garrido Salmon, Antonio Carlos dos Santos, Tonicarlo R. Velasco, Marcio Flavio D. Moraes, Joao Pereira Leite
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Condition:   Epilepsy Intervention:   Other: An App for reminding patients to take their medication Sponsor:   Tahel Ilan Ber Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Sophie Wilson-Smith, 24, from London, has focal seizures that can be unnoticeable to others, but she is 'freaking out inside'. It took more than a year for her to diagnosed with epilepsy.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Epilepsy is a neurological disease characterized by unprovoked seizures in the brain. The recent advances in sensor technologies allow researchers to analyze the collected biological records to improve the tre...
Source: BMC Systems Biology - Category: Molecular Biology Authors: Tags: Research Source Type: research
The objectives of this study were to report the frequency of seizure occurring while driving, clarify patient characteristics and analyze the behavioral patterns of drivers afflicted by seizur...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news
Shu-Fang Chen, Shuo-Bin Jou, Nai-Ching Chen, Hung-Yi Chuang, Chi-Ren Huang, Meng-Han Tsai, Teng-Yeow Tan, Wan-Chen Tsai, Chiung-Chih Chang, Yao-Chung Chuang
Source: Frontiers in Neurology - Category: Neurology Source Type: research
(University of North Carolina Health Care) Angelman syndrome is a genetic disease with no cure. Children grow up with severe intellectual disabilities and a range of other problems, arguably the worst of which are epileptic seizures. Now scientists at the UNC School of Medicine have found evidence that genetic therapy may prevent the enhanced seizure susceptibility.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Angelman syndrome (AS) is a neurodevelopmental disorder in which epilepsy is common (~90%) and often refractory to antiepileptics. AS is caused by mutation of the maternal allele encoding the ubiquitin protein ligase E3A (UBE3A), but it is unclear how this genetic insult confers vulnerability to seizure development and progression (i.e., epileptogenesis). Here, we implemented the flurothyl kindling and retest paradigm in AS model mice to assess epileptogenesis and to gain mechanistic insights owed to loss of maternal Ube3a. AS model mice kindled similarly to wild-type mice, but they displayed a markedly increased sensitivi...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
ConclusionOver a 4-year period, cannabidiol was effective in 26.9% of children with otherwise refractory epilepsy. It was well tolerated in about 20% of patients, but 80.8% had adverse events, including 23.1% with serious adverse events. Decreased appetite and diarrhea were frequent along with weight loss that became evident only later in the treatment.
Source: CNS Drugs - Category: Neurology Source Type: research
(MedPage Today) -- Late-onset epilepsy, APOE status raised mortality risk substantially
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Biomedical Science | Brain | Epilepsy | Genetics | Neurology | Respiratory Medicine | Sodium